Search Results

Site Search

IgA-mediated autoimmune bullous dermatoses - Insights

In this month’s “Hot Topic,” Julia Lehman, M.D., will discuss autoimmune bullous dermatoses, the rare category of blistering skin diseases that are caused by the development of autoantibodies against various constitutive parts of the...

Email Management and Tips - Insights

Opening your email inbox is like being dealt a hand of cards. You don’t know what you’ll get, you may be caught off guard, and you need to determine how to play out the hand you’ve been dealt. Thomas Huntley, MT(ASCP), Education...

Supporting Patient Care through Comprehensive Molecular and Cytogenetic Neuro-Oncology Testing - Insights

At Mayo Clinic, we offer a comprehensive approach to testing that focuses on the best outcomes for the patient. Our testing method combines molecular and cytogenetic analysis (in addition to a standard morphological and histological...

Subspecialty testing - Insights

Check out Mayo Clinic Laboratories’ comprehensive selection of pathology testing, which can guide diagnosis of malignancies and other diseases.

Familial studies - Insights

At Mayo Clinic Laboratories, familial variant analysis can clarify genetic variants in family members when a variant of interest has been previously identified.

Oral fluid panel - Insights

Find out more about our cost-effective immunoassay panel, which uses oral fluid testing to support addiction treatment and pain management.

Laboratories: Preparedness Planning, Continuity of Operations Planning, and Disaster Response Lessons Learned - Insights

Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, chatted with Shayne Brannman, Director of ASPR-TRACIE, and her team regarding clinical laboratories and how they plan for and respond to disasters. View this post for great resources that...

Myasthenia Gravis Testing - Mayo Clinic Laboratories

Our diagnostic algorithms consist of tests that are always performed, and then additional testing is performed depending on the initial results.

Dementia with Lewy bodies, Parkinson's, and multiple system atrophy - Insights

Learn more about how Mayo Clinic Laboratories' cerebrospinal fluid biomarker test for synucleinopathies, such as Parkinson’s disease and dementia with Lewy bodies, can accurately identify α-syn pathology even before definitive symptoms...

Leveraging the Laboratory - Insights

A Mayo Clinic podcast for administrators, outreach managers, and laboratory professionals hosted by Jane Hermansen, outreach manager at Mayo Clinic Laboratories, on how to best leverage and optimize the laboratory for patients, clients, and...